Lexagene Holdings (Lexagene Holdings) Research & Development : $4.51 Mil (TTM As of Nov. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Lexagene Holdings's Research & Development for the three months ended in Nov. 2022 was $0.89 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Nov. 2022 was $4.51 Mil.

Lexagene Holdings Research & Development Historical Data

The historical data trend for Lexagene Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Research & Development Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Research & Development

Get a 7-Day Free Trial

2.49

5.38

4.46

5.81

5.89

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Research & Development	Get a 7-Day Free Trial															1.51	1.18	1.33	1.12	0.89

Lexagene Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.51 Mil.

Lexagene Holdings (OTCPK:LXXGQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lexagene Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.